Found 134 results
E. G. Muldoon, Sharman, A., Page, I., Bishop, P., and Denning, D. W., Aspergillus nodules; another presentation of Chronic Pulmonary Aspergillosis., BMC Pulm Med, vol. 16, no. 1, p. 123, 2016.
M. D. Richardson and Page, I. D., Aspergillus serology: Have we arrived yet?, Med Mycol, 2016.
J. King, Richardson, M., Quinn, A. - M., Holme, J., and Chaudhuri, N., Bagpipe lung; a new type of interstitial lung disease?, Thorax, 2016.
H. C. Gugnani and Denning, D. W., Burden of serious fungal infections in the Dominican Republic., J Infect Public Health, vol. 9, no. 1, pp. 7-12, 2016.
J. Giacomazzi, Baethgen, L., Carneiro, L. C., Millington, M. Adelaide, Denning, D. W., Colombo, A. L., and Pasqualotto, A. C., The burden of serious human fungal infections in Brazil., Mycoses, vol. 59, no. 3, pp. 145-50, 2016.
K. Al-Shair, Muldoon, E. G., Morris, J., Atherton, G. T., Kosmidis, C., and Denning, D. W., Characterisation of fatigue and its substantial impact on health status in a large cohort of patients with chronic pulmonary aspergillosis (CPA)., Respir Med, vol. 114, pp. 117-22, 2016.
C. Kosmidis, Newton, P., Muldoon, E. G., and Denning, D. W., Chronic fibrosing pulmonary aspergillosis: a cause of 'destroyed lung' syndrome., Infect Dis (Lond), pp. 1-6, 2016.
D. W. Denning, Cadranel, J., Beigelman-Aubry, C., Ader, F., Chakrabarti, A., Blot, S., Ullmann, A. J., Dimopoulos, G., and Lange, C., Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management., Eur Respir J, vol. 47, no. 1, pp. 45-68, 2016.
J. S. Bartholomew, Banfield, S., Atherton, G. T., and Denning, D. W., Comment on: Antifungal therapy: drug-drug interactions at your fingertips., J Antimicrob Chemother, vol. 71, no. 7, p. 2062, 2016.
I. D. Page, Richardson, M. D., and Denning, D. W., Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA)., J Infect, vol. 72, no. 2, pp. 240-9, 2016.
B. L. Jones, Richardson, M. D., Ingram, P. M., and Agrawal, S. G., A CONSORT analysis of randomised controlled trials for the treatment of invasive aspergillosis., Med Mycol, 2016.
F. Gsaller, Hortschansky, P., Furukawa, T., Carr, P. D., Rash, B., Capilla, J., Müller, C., Bracher, F., Bowyer, P., Haas, H., Brakhage, A. A., and Bromley, M. J., Correction: Sterol Biosynthesis and Azole Tolerance Is Governed by the Opposing Actions of SrbA and the CCAAT Binding Complex., PLoS Pathog, vol. 12, no. 12, p. e1006106, 2016.
R. O. Oladele, Akanmu, A. S., Nwosu, A. O., Ogunsola, F. T., Richardson, M. D., and Denning, D. W., Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence., Open Forum Infect Dis, vol. 3, no. 2, p. ofw055, 2016.
B. Phj Thomma and Bignell, E., Editorial overview: The fungal infection arena in animal and plant hosts: dynamics at the interface., Curr Opin Microbiol, vol. 32, p. v-vii, 2016.
M. Sintes, De Moliner, F., Caballero-Lima, D., Denning, D. W., Read, N. D., Kielland, N., Vendrell, M., and Lavilla, R., Electrophilic, Activation-Free Fluorogenic Reagent for Labeling Bioactive Amines., Bioconjug Chem, vol. 27, no. 6, pp. 1430-4, 2016.
M. N. Gamaletsou, Drogari-Apiranthitou, M., Denning, D. W., and Sipsas, N. V., An estimate of the burden of serious fungal diseases in Greece., Eur J Clin Microbiol Infect Dis, vol. 35, no. 7, pp. 1115-20, 2016.
J. Abuga Guto, Bii, C. C., and Denning, D. W., Estimated burden of fungal infections in Kenya., J Infect Dev Ctries, vol. 10, no. 8, pp. 777-84, 2016.
M. Pegorie, Denning, D. W., and Welfare, W., Estimating the burden of Invasive and Serious Fungal Disease in the United Kingdom., J Infect, 2016.
J. - P. Gangneux, Bougnoux, M. - E., Hennequin, C., Godet, C., Chandenier, J., Denning, D. W., and Dupont, B., An estimation of burden of serious fungal infections in France., J Mycol Med, vol. 26, no. 4, pp. 385-390, 2016.
J. M. Alshehri, Caballero-Lima, D., M Hillarby, C., Shawcross, S. G., Brahma, A., Carley, F., Read, N. D., and Radhakrishnan, H., Evaluation of Corneal Cross-Linking for Treatment of Fungal Keratitis: Using Confocal Laser Scanning Microscopy on an Ex Vivo Human Corneal Model., Invest Ophthalmol Vis Sci, vol. 57, no. 14, pp. 6367-6373, 2016.
J. D. Oliver, Sibley, G. E. M., Beckmann, N., Dobb, K. S., Slater, M. J., McEntee, L., Pré, Sdu, Livermore, J., Bromley, M. J., Wiederhold, N. P., Hope, W. W., Kennedy, A. J., Law, D., and Birch, M., F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase., Proc Natl Acad Sci U S A, 2016.
N. L. D. Overton, Denning, D. W., Bowyer, P., and Simpson, A., Genetic susceptibility to allergic bronchopulmonary aspergillosis in asthma: a genetic association study., Allergy Asthma Clin Immunol, vol. 12, p. 47, 2016.
M. Kneale, Bartholomew, J. S., Davies, E., and Denning, D. W., Global access to antifungal therapy and its variable cost., J Antimicrob Chemother, 2016.
P. J. Newton, Harris, C., Morris, J., and Denning, D. W., Impact of liposomal amphotericin B therapy on chronic pulmonary aspergillosis., J Infect, 2016.
M. D. Richardson, An introduction to antifungal stewardship., J Antimicrob Chemother, vol. 71, no. suppl 2, p. ii3, 2016.